The one-stop recurrent miscarriage clinic: An evaluation of its effectiveness and outcome

Human Reproduction

Volumn 19, Issue 12, 2004, Pages 2952-2958

  Habayeb, Osama M H ^a   Konje, Justin C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

One stop clinic; Recurrent miscarriage

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; CHILDBIRTH; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; MEDICAL PRACTICE; PATIENT REFERRAL; PRACTICE GUIDELINE; PREGNANCY RATE; PREGNANCY TERMINATION; PRENATAL CARE; PREVALENCE; RECURRENT ABORTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOPHILIA;

EID: 11144301232     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh532     Document Type: Article

References (24)

1. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z and Younis JS (2000) Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 83,693-697.
2. Chamley LW, Duncalf AM, Mitchell MD and Johnson PM (1998) Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352,1037-1038.
3. Clifford K, Rai R and Regan L (1997) Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 12,387-389.
4. Coulam CB, Krysa L, Stern JJ and Bustillo M (1995) Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 34,333-337.
5. Drakeley AJ, Quenby S and Farquharson RG (1998) Mid-trimester loss - appraisal of a screening protocol. Hum Reprod 13,1975-1980.
6. Farquharson RG, Quenby S and Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100,408-413.
7. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G and Di Minno G (1997) Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 77,822-824.
8. Granger KA and Farquharson RG (1997) Obstetric outcome in antiphospholipid syndrome. Lupus 6,509-513.
9. Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174,1584-1589.
10. Li TC, Makris M, Tomsu M, Tuckerman E and Laird S (2002a) Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 8,463-481.
11. Li TC, Iqbal T, Anstie B, Gillham J, Amer S, Wood K and Laird S (2002b) An analysis of the pattern of pregnancy loss in women with recurrent miscarriage. Fertil Steril 78,1100-1106.
12. Liddell HS, Pattison NS and Zanderigo A (1991) Recurrent miscarriage - outcome after supportive care in early pregnancy. Aust NZ J Obstet Gynaecol 31,320-322.
13. Morikawa M, Yamada H, Kato EH, Shimada S, Sakuragi N, Fujimoto S and Minakami H (2003) Live birth rate varies with gestational history and etiology in women experiencing recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 109,21-26.
14. Nelen WL, Blom HJ, Steegers EA, den Heijer M and Eskes TK (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 74,1196-1199.
15. Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS and McDougall J (2000) Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183,1008-1012.
16. Quenby SM and Farquharson RG (1993) Predicting recurring miscarriage: what is important? Obstet Gynecol 82,132-138.
17. Quenby SM and Farquharson RG (1994) Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial. Fertil Steril 62,708-710.
18. Rai R, Cohen H, Dave M and Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 314,253-257.
19. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K and Regan L (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16,961-965.
20. Royal College of Obstetricians and Gynaecologists (2003) Guidelines, No 17. The investigation and treatment of couples with recurrent miscarriage. Revised May 2003
21. Stephenson MD, Dreher K, Houlihan E and Wu V (1998) Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 39,82-88.
22. Stray-Pedersen B and Stray-Pedersen S (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148,140-146.
23. Vossen CY, Preston FE, Conard J, Fontcuberta J, Makris M, van der Meer FJ, Pabinger I, Palareti G, Scharrer I, Souto JC et al. (2004) Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost 2,592-596.
24. Younis JS, Ohel G, Brenner B, Haddad S, Lanir N and Ben-Ami M (2000) The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation. Br J Obstet Gynecol 107,415-419.